हिंदी में पढ़ें

Laurus Labs

Laurus Labs shares tank on weak Q3 results; is it a good time to sell the stock?

Laurus Labs shares tank on weak Q3 results; is it a good time to sell the stock?

Thu, Jan 25, 2024

As of 10:37 a.m., shares of Laurus Labs traded 7.14 per cent, or Rs 28.45, lower on the BSE at Rs 370.1 apiece. The market capitalisation of the company at around the same time stood at Rs 19,947.13 crore.

Laurus Labs dividend: Company announces 20% payout—checkout record date, payout date

Laurus Labs dividend: Company announces 20% payout—checkout record date, payout date

Fri, Oct 20, 2023

Laurus Labs dividend: Laurus Labs on Friday, October 20 announced a 20 per cent payout to its shareholders for the financial year 2023-24 along with its quaterly earning report.

Lauras Labs-IIT Kanpur to bring novel gene therapy assets to market

Lauras Labs-IIT Kanpur to bring novel gene therapy assets to market

Mon, Jun 19, 2023

The two partners have signed a Memorandum of Understanding under which Laurus Labs will in-license few gene therapy assets and provide research grants for advancing these products through the pre-clinical development, the company said in a regulatory filing.

TRENDING NOW

Laurus Labs Share Price: Company forays into Lucrative Biotech Space

Laurus Labs Share Price: Company forays into Lucrative Biotech Space

Fri, Nov 27, 2020

The acquisition is likely to be positive for Laurus as it highly compliments the company’s aggressive growth plans and also offers a new revenue stream. Laurus’s existing business is also on a strong footing with the formulations segment being a key growth driver. The acquisition of RLPL abates concerns around utilisation of higher cash on Laurus’s books and this bodes well.

Super-Exclusive Interview: Anil Singhvi in chat with Laurus Labs' Founder and CEO Satyanarayana Chava

Super-Exclusive Interview: Anil Singhvi in chat with Laurus Labs' Founder and CEO Satyanarayana Chava

Fri, Oct 30, 2020

The strong results of Q2 are because of the hard work of the entire team and the capex incurred by the company during the inception and over the years.

Laurus Labs set for stock trading debut from December 19

Laurus Labs set for stock trading debut from December 19

Sun, Dec 18, 2016

Drugmaker Laurus Labs, which raised about Rs 1,332 crore through its initial public offer (IPO), is all set to make a debut on the stock exchanges on Monday.

Laurus Labs IPO fully subscribed

Laurus Labs IPO fully subscribed

Thu, Dec 08, 2016

On NSE, at 1.55 pm, the IPO's qualified institutional buyers (QIB) segment was subscribed by 1.28 times with over 79 lakh of bid received for 61.74 lakh shares issued.

Is Laurus Lab IPO a good deal for investors?

Is Laurus Lab IPO a good deal for investors?

Tue, Dec 06, 2016

Akash Jain, Research Analyst at Ajcon Global said, “At the upper price band, the IPO is valued at 30x at H1FY17 annualised Post issue EPS which is at a premium to its peers.”

Laurus Labs' Rs 1,332-crore IPO to hit market on December 6

Laurus Labs' Rs 1,332-crore IPO to hit market on December 6

Sun, Dec 04, 2016

Pharmaceutical firm Laurus Labs will hit the capital market this week to raise an estimated Rs 1,332 crore through its initial public offering (IPO). The IPO is scheduled to open on December 6 and close on December 8.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x